Status:
TERMINATED
Injectable Bulking Agent Needle Guide
Lead Sponsor:
Carbon Medical Technologies
Conditions:
Urinary Incontinence
Intrinsic Sphincter Deficiency
Eligibility:
FEMALE
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the use of the Needle Guide as an assist in properly guiding an injection needle into the appropriate tissue plane during an injectable bulking agent procedure...
Eligibility Criteria
Inclusion
- Individuals satisfying the "Indications" and "Contraindications" criteria in the Durasphere EXP Directions for Use may participate.
Exclusion
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00763711
Start Date
June 1 2008
End Date
November 1 2009
Last Update
January 10 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Jacksonville
Jacksonville, Florida, United States, 32224
2
Advanced Urogynecology
West Chester, Ohio, United States, 45069